Biogen to invest $2 billion to expand manufacturing capability in North Carolina
Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date
Investment builds on Biogen’s 30-year history of manufacturing in the region, with approximately $10 billion invested to date
Aims to support healthcare practitioners with evidence-based cough categorization tools that enable choosing the right molecules for effective & targeted relief from cough
Phosphate-based excipients provide higher bulk densities and enable the reduction of the tablet sizes
This marks the fourth acquisition by Corona Remedies from multinational corporations
Enables additional US manufacturing capacity to serve increased demand for pharma/biotech customers
The campaign celebrates radiant, healthy skin that shines naturally, empowering women to step forward with confidence in every walk of life.
Godavari Biorefineries receives patent from CNIPA
Subscribe To Our Newsletter & Stay Updated